BioLife Solutions, Inc. (BLFS) Operating margin 2017–2025
BioLife Solutions, Inc. (BLFS) operating margin by fiscal year — reported operating income divided by reported revenue.
-17.3%FY2025 · since FY2017: -9.6% → -17.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -17.3% | -11.3 pp |
| FY2024 | -6.0% | +19.3 pp |
| FY2023 | -25.3% | -17.5 pp |
| FY2022 | -7.8% | +21.7 pp |
| FY2021 | -29.5% | -16.5 pp |
| FY2020 | -13.0% | -12.2 pp |
| FY2019 | -0.8% | -19.4 pp |
| FY2018 | 18.5% | +28.1 pp |
| FY2017 | -9.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BLFS financial trends
BLFS RevenueBLFS Net incomeBLFS Net marginBLFS Gross profitBLFS Gross marginBLFS Operating incomeBLFS Operating cash flowBLFS Free cash flowBLFS Capital expendituresBLFS Return on equityBLFS Stock buybacksBLFS Dividends paidBLFS Total assetsBLFS Total liabilitiesBLFS Shareholders’ equityBLFS overview →